Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentOpen to AccrualParticipants Off Study and Primary Analysis CompletedPendingTemporarily Closed (Paused) to Accrual and Study Agents/ProductsWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 117 studies. 1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded P1074: IMPAACT LTFU Study DAIDS Number 10660 Research Area Complications & Comorbidities Study Status Concluded P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Participants Off Study and Primary Analysis Completed P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded P1071: CCR5 Vicriviroc (SCH-417690) DAIDS Number 10634 Research Area N/A Study Status Concluded P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed P1069: GPO-VIR Z30 DAIDS Number 10620 Research Area Other Study Status Concluded P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded Pagination Previous page Prev Page 1 … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Page 12 Next page Next
1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded
P1074: IMPAACT LTFU Study DAIDS Number 10660 Research Area Complications & Comorbidities Study Status Concluded
P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Participants Off Study and Primary Analysis Completed
P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded
P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed
P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
